4572 — Carna Biosciences Share News
0.000.00%
Table: Garna Biosciences -2022 group results
Table: Garna Biosciences -2022 group forecast
Table: Garna Biosciences - 9-MTH group results
Table: Garna Biosciences - 6-MTH group results
Table: Garna Biosciences -Q1 group results
Table: Garna Biosciences -2021 group results
Table: Garna Biosciences -2021 parent results
Brief: Brickell Biotech Acquires Exclusive Global Rights To Portfolio Of Novel Sting Inhibitors
Table: Garna Biosciences -2021 group forecast
Table: Garna Biosciences - 9-MTH group results
Table: Garna Biosciences - 6-MTH group results
Table: Garna Biosciences -Q1 group results
Table: Garna Biosciences -2020 group results
Table: Garna Biosciences -2020 parent results
Table: Garna Biosciences -2020 group forecast
Table: Garna Biosciences - 9-MTH group results
Table: Garna Biosciences - 6-MTH group results
Table: Garna Biosciences -Q1 group results
Table: Garna Biosciences -2019 parent results